Bill Gillette

Articles by Bill Gillette

The Food and Drug Administration has approved Onexton Gel (clindamycin phosphate and benzoyl peroxide 1.2 percent/3.75 percent, Valeant Pharmaceuticals) for the once-daily treatment of comedonal and inflammatory acne in patients 12 and older.

Though it’s known that oral contraceptive pills (OCPs) and systemic antibiotics are both effective in managing acne, there’s been precious little research comparing the two therapies head-to-head - until now.

According to an opinion piece published in JAMA Dermatology, when considering the appropriate ages for aesthetic procedures, the question isn’t so much, “What age is too young” as it is, “What age is too old?”

Latest Updated Articles